Notably, EV-mediated α-synuclein spread is not limited to the central nervous system; EVs from peripheral sources, such as erythrocytes, can carry α-synuclein across the blood–brain barrier under inflammatory conditions, inducing microglial activation and promoting PD pathology further [72]. Here, SNCA is linked to Parkinson disease.